Michael Wyand

Michael Wyand is a declared insider of EPIRUS Biopharmaceuticals, Inc., with filings sourced from SEC (Form 4). Between 15 July 2014 and 27 February 2016, the trades on record add up to 8 filings.

Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

The latest filing, published on 11 March 2016, reports an option exercise in EPIRUS Biopharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.